Study Combining Suicide Gene Therapy With Chemoradiotherapy in the Treatment of Non-Metastatic Pancreatic Adenocarcinoma
- Status
- TERMINATED
- Phase
- PHASE1
Clinical Trials Related to Pancreatic Cancer
Related studies linked through entity extraction aliases.
An Imaging Study of [18]F-fluoro-3'-Deoxy-3'-L-fluorothymidine ([18]F-FLT) in Patients With Locally Advanced or Metastatic Pancreatic Cancer Who Will be Treated With Gemcitabine or Other Nucleoside Analogs
- Status
- TERMINATED
- Phase
- EARLY_PHASE1
A Phase I/II, Multi-Center, Open-Label, Dose-Escalation, Safety and Efficacy Study of PHY906 Plus Capecitabine in Patients With Advanced Pancreatic Carcinoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Gemcitabine and Bevacizumab in Treating Patients With Pancreatic Cancer That Has Been Completely Removed By Surgery
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
RAD001 in Previously Treated Patients With Metastatic Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Cetuximab, Gemcitabine, and Oxaliplatin Followed By Surgery or External-Beam Radiation Therapy and Capecitabine in Treating Patients With Locally Advanced, Nonmetastatic Pancreatic Cancer That Cannot Be Removed By Surgery
- Status
- COMPLETED
- Phase
- PHASE2
Talimogene Laherparepvec in Patients With Unresectable Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Volociximab in Combination With Gemcitabine in Metastatic Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Chemoradiation-Induced Nausea and Emesis: Quality of Life
- Status
- TERMINATED
- Phase
- N/A
Adjuvant GVAX Vaccine Therapy in Patients With Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Escitalopram in Treating Depression in Patients With Advanced Lung or Gastrointestinal Cancer
- Status
- TERMINATED
- Phase
- PHASE3
Study of Mitomycin-C in Patients With Advanced or Recurrent Pancreatic Cancer With Mutated BRCA2 Gene
- Status
- WITHDRAWN
- Phase
- PHASE2
Eribulin Mesylate as Second-Line Therapy for Locally Advanced, Unresectable, or Metastatic Pancreatic Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Romidepsin (Depsipeptide) in Combination With Gemcitabine in Patients With Pancreatic and Other Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
131-I-TM-601 Study in Adults With Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Zinc Supplements in Lowering Cadmium Levels in Smokers
- Status
- COMPLETED
- Phase
- PHASE2
Genistein, Gemcitabine, and Erlotinib in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Phase I Study of Gemcitabine, Sorafenib and Radiotherapy in Patients With Unresectable Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1
AZD6244 vs. Capecitabine (Xeloda®) in Patients With Advanced or Metastatic Pancreatic Cancer, Who Have Failed First Line Gemcitabine Therapy
- Status
- COMPLETED
- Phase
- PHASE2
Changes in Muscle Tissue in Patients With Pancreatic Cancer
- Status
- COMPLETED
- Phase
- N/A